207 related articles for article (PubMed ID: 25877525)
1. Combined local and systemic antibiotic treatment is effective against experimental Staphylococcus aureus peri-implant biofilm infection.
van der Horst AS; Medda S; Ledbetter E; Liu A; Weinhold P; Del Gaizo DJ; Dahners L
J Orthop Res; 2015 Sep; 33(9):1320-6. PubMed ID: 25877525
[TBL] [Abstract][Full Text] [Related]
2. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
3. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model.
Lucke M; Wildemann B; Sadoni S; Surke C; Schiller R; Stemberger A; Raschke M; Haas NP; Schmidmaier G
Bone; 2005 May; 36(5):770-8. PubMed ID: 15794930
[TBL] [Abstract][Full Text] [Related]
4. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Edmiston CE; Goheen MP; Seabrook GR; Johnson CP; Lewis BD; Brown KR; Towne JB
Am J Surg; 2006 Sep; 192(3):344-54. PubMed ID: 16920429
[TBL] [Abstract][Full Text] [Related]
5. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
Richards GK; Morcos RJ; Gagnon RF
Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
[TBL] [Abstract][Full Text] [Related]
6. Local antibiotic delivery by a bioabsorbable gel is superior to PMMA bead depot in reducing infection in an open fracture model.
Penn-Barwell JG; Murray CK; Wenke JC
J Orthop Trauma; 2014 Jun; 28(6):370-5. PubMed ID: 23948961
[TBL] [Abstract][Full Text] [Related]
7. Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study.
Yarboro SR; Baum EJ; Dahners LE
J Bone Joint Surg Am; 2007 May; 89(5):929-33. PubMed ID: 17473127
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
9. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
10. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
11. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
Gagnon RF; Richards GK; Kostiner GB
Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
[TBL] [Abstract][Full Text] [Related]
12. Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
Shiels SM; Tennent DJ; Akers KS; Wenke JC
Injury; 2017 Oct; 48(10):2095-2100. PubMed ID: 28842287
[TBL] [Abstract][Full Text] [Related]
13. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections.
Chilukuri DM; Shah JC
Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review.
Schmidmaier G; Lucke M; Wildemann B; Haas NP; Raschke M
Injury; 2006 May; 37 Suppl 2():S105-12. PubMed ID: 16651063
[TBL] [Abstract][Full Text] [Related]
15. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
[TBL] [Abstract][Full Text] [Related]
16. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Minimum Biofilm Eradication Concentration (MBEC) on
Okae Y; Nishitani K; Sakamoto A; Kawai T; Tomizawa T; Saito M; Kuroda Y; Matsuda S
Front Cell Infect Microbiol; 2022; 12():896978. PubMed ID: 35846761
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
Salem AH; Elkhatib WF; Noreddin AM
J Pharm Pharmacol; 2011 Jan; 63(1):73-9. PubMed ID: 21155818
[TBL] [Abstract][Full Text] [Related]
19. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment.
Broekhuizen CA; de Boer L; Schipper K; Jones CD; Quadir S; Vandenbroucke-Grauls CM; Zaat SA
J Biomed Mater Res A; 2008 May; 85(2):498-505. PubMed ID: 17729261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
